| Stability and Beyond Use Dates |
CE Credits; Health Care Professionals; Case Study; Podcasts; Videos; Webinars |
Compounding; Disease States; Drug Development; Drug Regulatory Process; Drug Safety; MedWatch |
| FDA D.I.S.C.O. Burst Edition: FDA approval of Tafinlar (dabrafenib) with Mekinist (trametinib) for pediatric patients with low-grade glioma with a BRAF V600E mutation |
Health Care Professionals; Patients; Podcasts |
Cancer Drugs; Disease States; Drug Development; Drug Regulatory Process; Drug Safety |
| FDA approval of Verzenio (abemaciclib) |
Health Care Professionals; Patients; Podcasts; Women’s Health |
Cancer Drugs; Disease States; Drug Development; Drug Regulatory Process; Drug Safety |
| FDA approval of Jemperli (dostarlimab-gxly) |
Health Care Professionals; Patients; Podcasts; Women’s Health |
Cancer Drugs; Disease States; Drug Development; Drug Regulatory Process; Drug Safety |
| FDA approval of Trodelvy (sacituzumab govitecan-hziy) |
Health Care Professionals; Patients; Podcasts; Women’s Health |
Cancer Drugs; Disease States; Drug Development; Drug Regulatory Process; Drug Safety |
| FDA approvals of Jaypirca (pirtobrutinib) and Orserdu (elacestrant) |
Health Care Professionals; Patients; Podcasts; Women’s Health |
Cancer Drugs; Disease States; Drug Development; Drug Regulatory Process; Drug Safety |
| FDA approval of Keytruda (pembrolizumab) |
Health Care Professionals; Patients; Podcasts |
Cancer Drugs; Disease States; Drug Development; Drug Regulatory Process; Drug Safety |
| FDA approvals of Tukysa (tucatinib) |
Health Care Professionals; Patients; Podcasts |
Cancer Drugs; Disease States; Drug Development; Drug Regulatory Process; Drug Safety |
| Biosimilars: What Patients Need to Know |
Patients; Graphics |
Biosimilars; Diabetes; Disease States; Drug Development; Drug Regulatory Process; Drug Safety; Generic Drugs |
| Biosimilars: What Patients With Diabetes Need To Know |
Patients; Graphics |
Biosimilars; Diabetes; Disease States; Drug Development; Drug Regulatory Process; Drug Safety; Generic Drugs |
| Biosimilar Basics |
Patients; Graphics |
Biosimilars; Diabetes; Disease States; Drug Development; Drug Regulatory Process; Drug Safety; Generic Drugs |
| Biosimilares: Lo que los pacientes deben saber |
Patients; Graphics |
Biosimilars; Diabetes; Disease States; Drug Development; Drug Regulatory Process; Drug Safety; Generic Drugs |
| Biosimilares: Lo que los pacientes con diabetes deben saber |
Patients; Graphics |
Biosimilars; Diabetes; Disease States; Drug Development; Drug Regulatory Process; Drug Safety; Generic Drugs |
| Conceptos básicos sobre los biosimilares |
Patients; Graphics |
Biosimilars; Diabetes; Disease States; Drug Development; Drug Regulatory Process; Drug Safety; Generic Drugs |
| Biosimilar Basics for Patients |
Patients; Graphics |
Biosimilars; Diabetes; Disease States; Drug Development; Drug Regulatory Process; Drug Safety; Generic Drugs |
| Airflow |
Health Care Professionals; Graphics; Webinars |
Compounding; Disease States; Drug Development; Drug Regulatory Process; Drug Safety |
| Personnel Gowning in Sterile Drug Production |
Health Care Professionals; Graphics; Webinars |
Compounding; Disease States; Drug Development; Drug Regulatory Process; Drug Safety |
| Insanitary Conditions and Sterility Assurance |
Health Care Professionals; Graphics; Webinars |
Compounding; Disease States; Drug Development; Drug Regulatory Process; Drug Safety |
| Supplier/Contractor Qualification and Management |
Health Care Professionals; Graphics; Webinars |
Compounding; Disease States; Drug Development; Drug Regulatory Process; Drug Safety |
| Investigations and Corrective and Preventive Actions (CAPA) |
Health Care Professionals; Graphics; Webinars |
Compounding; Disease States; Drug Development; Drug Regulatory Process; Drug Safety |
| Outsourcing Facility Guide |
Health Care Professionals; Graphics; Webinars |
Compounding; Disease States; Drug Development; Drug Regulatory Process; Drug Safety |
| Sterility Testing: Common Misconceptions |
Health Care Professionals; Graphics; Webinars |
Compounding; Disease States; Drug Development; Drug Regulatory Process; Drug Safety |
| Regulatory Framework for Human Drug Compounding |
Health Care Professionals; Graphics; Webinars |
Compounding; Disease States; Drug Development; Drug Regulatory Process; Drug Safety |
| Aseptic Process Simulations (Media Fills) |
Health Care Professionals; Graphics; Webinars |
Compounding; Disease States; Drug Development; Drug Regulatory Process; Drug Safety |
| MedWatch, Your Report Can Make a Difference with Dr. Gerald Dal Pan |
Health Care Professionals; Podcasts |
Disease States; Drug Development; Drug Regulatory Process; Drug Safety; Generic Drugs; MedWatch |
| Expanded Access with Dr. Jacqueline Corrigan-Curay |
Health Care Professionals; Patients; Graphics |
Disease States; Drug Development; Drug Regulatory Process; Drug Safety; IND |
| Are you on a biologic medication? |
Patients; Graphics |
Biosimilars; Disease States; Drug Development; Drug Regulatory Process; Drug Safety |
| Summary Report for Biosimilars |
Health Care Professionals; Patients; Graphics |
Biosimilars; Disease States; Drug Development; Drug Regulatory Process; Drug Safety |
| Biosimilars Multimedia Education Materials |
Health Care Professionals; Patients; Graphics; Podcasts; Social Media; Videos; Webinars |
Biosimilars; Disease States; Drug Development; Drug Regulatory Process; Drug Safety |
| Biosimilars Overview for Health Care Professionals |
Health Care Professionals; Graphics; Podcasts; Videos; Webinars |
Biosimilars; Disease States; Drug Development; Drug Regulatory Process; Drug Safety |
| FDA 101: An Overview of FDA’s Regulatory Review and Research Activities |
Health Care Professionals; Patients; Webinars |
Disease States; Drug Development; Drug Regulatory Process; Drug Safety; Generic Drugs; IND; OTC Drug Regulations; Women’s Health |
| FDA Insight |
Health Care Professionals; Patients; Podcasts |
Compounding; COVID-19; Disease States; Drug Development; Drug Regulatory Process; Drug Safety; Generic Drugs; Opioids; Women’s Health; OTC Drug Regulations |
| Health Equity Forum Podcast |
Health Care Professionals; Patients; Podcasts |
COVID-19; Disease States; Drug Development; Drug Regulatory Process; Drug Safety; Diabetes; Women’s Health |
| MedWatch, Your Report Can Make a Difference |
Health Care Professionals; Patients; Podcasts |
Drug Safety; MedWatch; Generic Drugs; Disease States; Drug Regulatory Process |
| Pregnancy and Lactation Medication Information for the Healthcare Provider |
CE Credits; Health Care Professionals; Webinars; Videos; Social Media |
Women’s Health; Disease States; Drug Regulatory Process; Drug Safety |
| Minority Health and Health Equity Webinars |
Health Care Professionals; Patients; Podcasts; Videos; Webinars |
Disease States; Drug Development; Drug Regulatory Process; Drug Safety |
| Why Does the FDA Exist? |
Health Care Professionals; Patients; Videos; Podcasts; Social Media |
Disease States; Drug Development; Drug Regulatory Process; Drug Safety |
| Achieving Data Quality and Integrity in Maximum Containment Laboratories |
Health Care Professionals; Patients; Webinars |
Disease States; Drug Development; Drug Regulatory Process; Drug Safety; |
| Topics in Public Health |
CE Credits; Health Care Professionals; Patients; Case Study; Webinars |
Biomarker; Biosimilars; Cancer Drugs; Compounding; COVID-19; Diabetes; Disease States; Drug Development; Drug Regulatory Process; Drug Safety; Generic Drugs; IND; MedWatch; Opioids; OTC Drug Regulations; Women’s Health |
| Conversations on Cancer: “What’s on the Horizon: Future of Cancer Care” |
Health Care Professionals; Patients; Webinars |
Cancer Drugs; Disease States |
| Conversations on Cancer: “Seasons of Change: Oncology Careers” |
Health Care Professionals; Patients; Webinars |
Cancer Drugs; Disease States |
| Application of Artificial Intelligence and Machine Learning for Precision Medicine |
Health Care Professionals; Patients; Webinars |
Disease States; Drug Development; Drug Regulatory Process; Drug Safety |
| Joint US FDA – Health Canada ICH Public Meeting |
Health Care Professionals; Patients; Webinars |
Disease States; Drug Development; Drug Regulatory Process; Drug Safety; IND |
| FDA Rare Disease Day 2023 |
Health Care Professionals; Patients; Webinars |
Biomarker; Disease States; Drug Development; Drug Regulatory Process; Drug Safety |
| Risk Evaluation and Mitigation Strategies (REMS) Program Part 1 |
Health Care Professionals; Patients; Graphics |
Disease States; Drug Development; Drug Regulatory Process; Drug Safety; Generic Drugs |
| Risk Evaluation and Mitigation Strategies (REMS) Program Part 2 |
Health Care Professionals; Patients; Graphics |
Disease States; Drug Development; Drug Regulatory Process; Drug Safety; Generic Drugs |
| International 2022 Drug-Induced Kidney Injury Biomarker Workshop Day 1 and Day 2 |
Health Care Professionals; Patients; Videos |
Biomarker; Disease States; Drug Development; Drug Regulatory Process |
| Advancing Regulatory Science at FDA |
Health Care Professionals; Patients; Graphics |
Biomarker; Disease States; Drug Development; Drug Regulatory Process |
| Accelerating Access to Critical Therapies for ALS |
Health Care Professionals; Patients; Graphics; Videos |
Biomarker; Disease States; Drug Development; Drug Regulatory Process |
| Accelerating Rare disease Cures (ARC) Program |
Health Care Professionals; Patients; Videos |
Biomarker; Disease States; Drug Development; Drug Regulatory Process |
| Successes and Opportunities in Modeling and Simulation for FDA |
Health Care Professionals; Patients; Graphics |
Biomarker; Disease States; Drug Development; Drug Regulatory Process |
| FDA’s Work to Combat the COVID-19 Pandemic |
Health Care Professionals; Patients; Graphics |
COVID-19; Disease States; Drug Development; Drug Regulatory Process; Drug Safety |
| Working with patient advocacy groups |
Health Care Professionals; Patients; Podcasts |
Biomarker; Disease States; Drug Development; Drug Regulatory Process; Drug Safety |
| Drug compounding |
Health Care Professionals; Patients; Podcasts |
Compounding; Disease States; Drug Development; Drug Regulatory Process; Drug Safety |
| Talking translational science |
Health Care Professionals; Patients; Podcasts |
Biomarker; Disease States; Drug Development; Drug Regulatory Process; Drug Safety |
| Addressing the Opioid Epidemic |
Health Care Professionals; Patients; Podcasts |
Disease States; Drug Development; Drug Regulatory Process; Drug Safety; Generic Drugs; MedWatch; Opioids |
| Antibiotic Misuse and Resistance |
Health Care Professionals; Patients; Podcasts |
Disease States; Drug Safety; MedWatch |
| FDA’s Adverse Event Reporting System (FAERS) |
Health Care Professionals; Patients; Podcasts |
Drug Safety; MedWatch; Generic Drugs |
| Breakthrough Therapy Designation |
Health Care Professionals; Patients; Podcasts |
Disease States; Drug Development; Drug Regulatory Process; Drug Safety |
| Biosimilars: Are they the same quality? |
Health Care Professionals; Patients; Graphics |
Biosimilars; Disease States; Drug Regulatory Process; Drug Development; Drug Safety |
| How to Use the Consumer Complaint System and MedWatch |
Health Care Professionals; Patients |
Drug Safety; MedWatch |
| Reporting Unlawful Sales of Medical Products on the Internet |
Health Care Professionals; Patients |
Drug Safety |
| Health Fraud Product Database |
Health Care Professionals; Patients |
Drug Safety |
| Compounding Outsourcing Facilities Annual Study |
Health Care Professionals; Patients; Webinars |
Compounding; Disease States; Drug Development; Drug Regulatory Process; Drug Safety |
| Compounding Quality Center of Excellence Virtual Conference |
Health Care Professionals; Patients; Webinars |
Compounding; Disease States; Drug Development; Drug Regulatory Process; Drug Safety |
| State of Outsourcing Facility Sector and Possibilities for the Future |
Health Care Professionals; Patients; Webinars |
Compounding; Disease States; Drug Development; Drug Regulatory Process; Drug Safety |
| Areas of Customer Need for Outsourcing Facility Products |
Health Care Professionals; Patients; Webinars |
Compounding; Disease States; Drug Development; Drug Regulatory Process; Drug Safety |
| Compounding Quality Center of Excellence Cross-Sector |
Health Care Professionals; Patients; Webinars |
Compounding; Disease States; Drug Development; Drug Regulatory Process; Drug Safety |
| Compounding Quality Center of Excellence Virtual Live Training |
CE Credits; Health Care Professionals; Case Study; Podcasts; Videos; Webinars |
Compounding; Disease States; Drug Development; Drug Regulatory Process; Drug Safety; MedWatch |
| Equity of Voices video series |
Health Care Professionals; Patients; Case Study; Podcasts; Videos; Webinars |
Disease States; Drug Development; Drug Regulatory Process; Drug Safety; Generic Drugs; MedWatch |
| Biosimilars in the Real World: Perspectives for Staying Within the Scope of Care |
CE Credits; Health Care Professionals; Case Study; Podcasts; Videos; Webinars |
Biosimilars; Cancer Drugs; Diabetes; Disease States; Drug Regulatory Process; Drug Development; Drug Safety; Generic Drugs; MedWatch |
| Pregnancy and Lactation Medication Information for the Healthcare Provider: |
Health Care Professionals; Patients; Webinars |
Disease States; Drug Development; Drug Regulatory Process; Drug Safety; Generic Drugs; MedWatch; Women’s Health |
| Leveraging Real-World Data to Study Medication Use in Pregnancy and Lactation |
Health Care Professionals; Patients; Webinars |
Disease States; Drug Development; Drug Regulatory Process; Drug Safety; Generic Drugs; MedWatch; Women’s Health |
| CBD and Other Cannabinoids: Sex and Gender Differences in Use and Responses |
Health Care Professionals; Patients; Webinars |
Cancer Drugs; Disease States; Drug Development; Drug Regulatory Process; Drug Safety; Generic Drugs; MedWatch; Opioids; Women’s Health |
| Opioid and Nicotine Use, Dependence, and Recovery: Influences of Sex and Gender |
Health Care Professionals; Patients; Webinars |
Cancer Drugs; Disease States; Drug Development; Drug Regulatory Process; Drug Safety; Generic Drugs; MedWatch; Opioids; Women’s Health |
| Maximizing Benefits and Minimizing Harms from Antibiotics |
Health Care Professionals; Patients; Webinars |
Disease States; Drug Development; Drug Regulatory Process; Drug Safety; Generic Drugs; MedWatch |
| Health Fraud Scams |
Health Care Professionals; Patients; Webinars |
Drug Safety |
| 6 Tip-Offs to Rip-Offs: Don’t Fall for Health Fraud Scams |
Health Care Professionals; Patients; Webinars |
Drug Safety |
| BeSafeRx: Your Source for Online Pharmacy Information |
Health Care Professionals; Patients; Webinars |
Drug Safety |
|
COVID-19 Health Care Professional Resources
|
Health Care Professionals; Patients; Podcasts; Videos |
COVID-19; Disease States; Drug Regulatory Process; Drug Development; Drug Safety; MedWatch |
| FDA’s Overdose Prevention Framework with Dr. Marta Sokolowska |
Health Care Professionals; Patients; Podcasts |
Disease States; Drug Regulatory Process; Drug Development; Drug Safety; MedWatch; Opioids; Cancer Drugs |
| FDA Health Playbook |
Health Care Professionals; Patients; Videos; Graphics; Podcasts; Social Media |
Drug Safety; OTC Drug Regulations; MedWatch; Opioids |
| 14th Annual Sentinel Initiative Public Workshop |
Health Care Professionals; Patients; Webinars |
COVID-19; Disease States; Drug Regulatory Process; Drug Development; Drug Safety |
| Medical Extended Reality: Applications and Challenges |
Health Care Professionals; Patients; Webinars |
Disease States; Drug Regulatory Process; Drug Development; Drug Safety |
|
Highlights in Oncofertility: Trends in an Emerging Field for Cancer Survivors
|
Health Care Professionals; Patients; Webinars |
Cancer Drugs; Disease States; Drug Regulatory Process; Drug Development; Drug Safety; Women’s Health |
| What does FDA regulate? |
Health Care Professionals; Patients; Videos; Graphics |
Disease States; Drug Regulatory Process; Drug Development; Drug Safety; Generic Drugs; OTC Drug Regulations; Women’s Health |
| FDA Grand Rounds |
Health Care Professionals; Patients; Webinars |
COVID-19; Disease States; Drug Regulatory Process; Drug Development; Drug Safety; MedWatch; Generic Drugs; OTC Drug Regulations; Biosimilars; IND; Cancer Drugs; Biomarker; Women’s Health |
| Safe Opioid Disposal |
Safe Opioid Disposal – Remove the Risk Outreach Toolkit |
Disease States; Drug Regulatory Process; Drug Development; Drug Safety; MedWatch; Generic Drugs; Cancer Drugs; Opioids |
| What Does FDA Do? |
Health Care Professionals; Patients; Videos |
Disease States; Drug Regulatory Process; Drug Development; Drug Safety; MedWatch; Generic Drugs; OTC Drug Regulations; IND; Women’s Health |
| Conversation on Paxlovid with Dr. John Farley |
Health Care Professionals; Patients; Podcasts |
COVID-19; Disease States; Drug Regulatory Process; Drug Development; Drug Safety |
| Clinical Trial Basics with Dr. Robert Temple |
Health Care Professionals; Patients; Podcasts |
Disease States; Drug Regulatory Process; Drug Development; Drug Safety; IND; Biomarker; Women’s Health |
| Biosimilars Patient Materials |
Graphics; Videos; Patients |
Biosimilars; Drug Regulatory Process; Drug Development; Disease States; Drug Safety |
| Clinical Trial Basics |
Health Care Professionals; Podcasts |
Biomarkers; Disease States; Drug Regulatory Process; Drug Development; Drug Safety; IND; Women’s Health |
| Adverse Events Associated with Compounded Drugs from Outsourcing Facilities |
Health Care Professionals; Case Study; Podcasts; Videos; Webinars |
Compounding; Disease States; Drug Development; Drug Regulatory Process; Drug Safety; MedWatch |
| Biosimilars 101: A Primer for Your Practice |
CE Credits; Health Care Professionals; Case Study |
Biosimilars; Cancer Drugs; Diabetes; Disease States; Drug Regulatory Process; Drug Development; Drug Safety; Generic Drugs; MedWatch; Women’s Health |
| Incorporating Biosimilars Into the Management of Patients With Immunological Conditions |
CE Credits; Health Care Professionals; Case Study |
Biosimilars; Cancer Drugs; Diabetes; Disease States; Drug Regulatory Process; Drug Development; Drug Safety; Generic Drugs; MedWatch; Women’s Health |
| Putting the Patient into Perspective: Strategies for Educating Patients about Biosimilars |
CE Credits; Health Care Professionals; Case Study; Podcasts; Videos; Webinars |
Biosimilars; Cancer Drugs; Diabetes; Disease States; Drug Regulatory Process; Drug Development; Drug Safety; Generic Drugs; MedWatch; Women’s Health |
| Biosimilars Resources |
Health Care Professionals; Case Study; Podcasts; Videos; Webinars |
Biosimilars; Drug Regulatory Process; Drug Development |
| Bridging Efficacy and Safety to the Obese |
Health Care Professionals; Webinars |
Biomarker; Cancer Drugs; Diabetes; Disease States; Drug Development; Drug Regulatory Process; Drug Safety; Generic Drugs; IND; MedWatch; Women’s Health |
| Engaging Providers to Address Knowledge Gaps on Medication Use in Pregnancy and Lactation |
CE Credits; Health Care Professionals; Webinars |
Disease States; Drug Development; Drug Regulatory Process; Drug Safety; Generic Drugs; MedWatch; Women’s Health |
| Biosimilars Videos |
Healthcare Professionals; Videos Biosimilars; Drug Regulatory Process |
Drug Development |
| Biosimilars Level 2: Regulatory and Scientific Concepts |
Case Study |
Health Care Professionals |
| Biosimilars Level 1: Foundational Concepts |
Case Study |
Health Care Professionals |
| Increasing the Efficiency of Biosimilar Development Programs |
Health Care Professionals; Webinars |
Biosimilars; Drug Regulatory Process; Drug Development |
| Successfully Navigating the USPTO and FDA |
CE Credits; Webinars |
Drug Development; Drug Regulatory Process; Drug Safety; Registration and Listing |
| The History of FDA |
Health Care Professionals; Webinars |
Drug Development; Drug Regulatory Process; Drug Safety |
| Bench to Bedside: Integrating Sex and Gender to Improve Human Health |
CE Credits; Health Care Professionals; Webinars |
Diabetes; Disease States; Drug Development; Drug Regulatory Process; Drug Safety; Women’s Health |
| Q&A with FDA |
Health Care Professionals; Podcasts |
COVID-19; Disease States; Drug Regulatory Process; Drug Development; Drug Safety; MedWatch |
| Biosimilars Level 1: Foundational Concepts |
Health Care Professionals; Case Study |
Biosimilars; Drug Regulatory Process; Drug Development |
| Biosimilars Level 2: Regulatory and Scientific Concepts |
Health Care Professionals; Case Study |
Biosimilars; Drug Regulatory Process; Drug Development |
| Biosimilars Curriculum Materials |
Health Care Professionals; Case Study; Podcasts; Videos; Webinars |
Biosimilars; Drug Regulatory Process; Drug Development |
| Drug Approval Case Studies |
Case Study; Health Care Professionals; Patients; Graphics |
Diabetes; Drug Development; Drug Regulatory Process; Drug Safety; Generic Drugs; IND |
| FDA’s Role in Public Health: Drug Efficacy, Safety, Quality, and Beyond |
Health Care Professionals; CE Credits |
Drug Regulatory Process |
| Practitioners’ Guide for Improving Oral Anticoagulant Use |
Health Care Professionals; CE Credits |
Oral Anticoagulant; Disease States |
| The FDA Bad Ad Program and Prescription Drug Promotion |
Health Care Professionals; CE Credits |
Prescription Drug Promotion |
| FDA MedWatch and Patient Safety |
Health Care Professionals |
MedWatch; Drug Safety |
| The FDA Process for Approving Generic Drugs |
Health Care Professionals |
Drug Regulatory Process; Drug Development; Generic Drugs |
| FDA Overview of Biosimilar Products |
Health Care Professionals; Videos |
Biosimilars; Drug Regulatory Process; Drug Development |
| Leveraging Health Literacy and Patient Preferences to Reduce Hypoglycemia Events in Patients with Type 2 Diabetes |
Health Care Professionals |
Diabetes; Disease States |
| Director’s Corner Podcasts |
Health Care Professionals; Podcasts |
Drug Regulatory Process; Drug Development; Compounding; Generic Drugs; Drug Safety; MedWatch; Disease States |
| Drug Information Soundcast in Clinical Oncology (D.I.S.C.O) |
Health Care Professionals; Podcasts |
Cancer Drugs; Disease States; Drug Regulatory Process; Drug Development; Drug Safety; Generic Drugs; MedWatch; Women’s Health |
| FDA Drug Safety Podcasts |
Health Care Professionals; Podcasts |
Drug Safety; Biosimilars; Cancer Drugs; Diabetes; Disease States; Drug Regulatory Process; Drug Development; Drug Safety; Generic Drugs; MedWatch; Women’s Health |
| Regulatory Science at CDER Podcasts |
Health Care Professionals; Podcasts |
Drug Development; Disease States; Drug Regulatory Process; Drug Safety; IND |
| FDA’s Biomarker Qualification Program |
Videos |
Biomarker; Drug Development |
| Biosimillars Health Care Provider Materials |
Health Care Professionals; Videos; Graphics; Social Media |
Biosimilars; Drug Regulatory Process; Drug Development; Disease States; Drug Safety |
| FDA Drug Info Rounds |
Health Care Professionals; Videos |
Drug Safety; MedWatch; IND; Drug Development; Drug Regulatory Process; Prescription Drug Promotion; Disease States; Registration and Listing; Generic Drugs |
| GDUFA II Videos and Resources |
Videos |
Drug Development; Generic Drugs |
| Regulatory Science at CDER Videos |
Videos |
Drug Regulatory Process; Drug Development |
| Biosimilars Online Courses, Webinars, and Presentations |
Health Care Professionals; Webinars |
Biosimliars; Drug Regulatory Process; Drug Development |
| CDER Webinars |
Health Care Professionals; Webinars |
Drug Regulatory Process; Drug Development; Generic Drugs; OTC Drug Regulations; Registration and Listing; Electronic Submissions; Biosimilars; Drug Safety; MedWatch; IND; Disease States; Prescription Drug Promotion; Cancer Drugs |
| Division of Drug Information Webinars |
Health Care Professionals; Webinars; CE Credits |
Drug Regulatory Process; Drug Development; Generic Drugs; OTC Drug Regulations; Biosimilars; Drug Safety; MedWatch; IND; Disease States; Prescription Drug Promotion; Cancer Drugs |
| Compounding Quality Center of Excellence On-Demand Training |
CE Credits; Health Care Professionals; Case Study; Podcasts; Videos; Webinars |
Compounding; Disease States; Drug Development; Drug Regulatory Process; Drug Safety; MedWatch |
